HDAC6 inhibitors such as ACY-1215 are currently in clinical studies for the treatment of multiple myeloma and have been found to have anti-inflammatory influences in osteoarthritis studies42,56. The gene discussed is HDAC6; the disease is plasma cell myeloma.